Audibert John 4

What Happened
John Audibert, Chief Scientific Officer and Chief Compliance Officer of Stran & Company, received an award/grant of 25,000 shares on February 19, 2026. The Form 4 reports an acquisition at $0.00 per share (total reported cash paid $0). This was an equity award (transaction code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-02-19; Form 4 filed: 2026-02-20 (appears timely). Accession: 0001213900-26-018872.
• Transaction type: Award/Grant (code A).
• Shares acquired: 25,000; reported price: $0.00; reported cash value: $0.
• Shares owned after transaction: not specified in the provided excerpt — see the full Form 4 for updated holdings.
• Footnotes/conditions: none shown in the excerpt (no 10b5-1 plan, tax withholding, or restriction details provided).

Context
Equity awards are commonly part of executive compensation or retention packages and do not directly signal buying or selling intent. For investors, note such grants can dilute outstanding shares and may be subject to vesting or transfer restrictions — check the full Form 4 and the company’s proxy/compensation disclosures for vesting terms and plan details.